Lightbridge outlines 1-year Phase 1 Stern Labs testing while expanding patent coverage across 39 European states

Q1 2026. Management view "We have made meaningful progress on several fronts in 2026" as Lightbridge "expanded our intellect ...
Hosted on MSN

Cannabis-based autism drug shines in phase-1 testing

・DeFloria, a joint venture between Charlotte’s Web (TSX:CWEB), Ajna BioSciences and British American Tobacco, yielded positive results from a phase-1 dose trial of AJA001, its cannabis-based drug ...